PHV-wordings
Here you will find safety-relevant information that must be implemented in the corresponding product information due to a PHV (pharmacovigilance) issues.
Due to the relaunch of the EMA website in December 2023, you will find the current links to the entries prior to December 01, 2023 at https://www.ema.europa.eu
Nefopam
PSUR-outcome
|
29/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Cefditoren
PSUR-outcome
|
16/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Codeine/paracetamol
PSUR-outcome
|
15/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Clomipramine
PSUR-outcome
|
09/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Clozapine
PSUR-outcome
|
09/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Varicella vaccine (live)
PSUR-outcome
|
09/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Selegiline
PSUR-outcome
|
09/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Rocuronium
PSUR-outcome
|
09/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Rifampicin
PSUR-outcome
|
08/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Prazepam
PSUR-outcome
|
08/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
